Navigation Links
Face Transplant Patient Can Smell, Taste, Breathe Normally

Nearly a year after groundbreaking surgery, gunshot victim continues to show improvement

TUESDAY, Nov. 17 (HealthDay News) -- The woman who underwent the first facial transplant in the United States can now smell, taste what she eats and breathe through her nose, according to a report from her surgeons.

Nearly a year after the surgery, blood vessels from the transplanted tissue have integrated with existing tissue, she has had no significant complications and her sensory and motor abilities, including the ability to speak, continue to improve, they say in the November/December issue of the Archives of Facial Plastic Surgery.

"This really does open up new frontiers both for transplanting more of the face and for offering it to individuals with previous reconstructive failures," said Dr. Wayne Larrabee, Jr., a clinical professor of head and neck surgery at the University of Washington in Seattle and editor of the journal.

Connie Culp, a mother and grandmother from Unionport, Ohio, was shot by her husband in a failed murder-suicide attempt in 2004. The shotgun blast destroyed the middle part of her face, including her nose and nasal passage, upper jaw and cheeks, and she lost her sight.

Though there were three face transplants performed worldwide before Culp's -- and a total of about seven to date -- Culp's "near-total" face transplant was among the most extensive ever performed. The surgery replaced much of the soft tissue of her face, the bony structure of the palate (roof of the mouth) and her upper jaw.

Making the surgery even more challenging, the transplant was a "salvage operation," done after Culp had endured 23 failed attempts at reconstructive surgery. The earlier operations caused extensive scarring and destroyed blood vessels, further complicating an already difficult task.

"This patient had undergone multiple previous procedures for reconstruction which had failed," Larrabee said. "This made the surgery much more difficult but the ethical decision very clear."

Last Dec. 9, eight surgeons from the Cleveland Clinic replaced 80 percent of Culp's face and jaw during a 22-hour operation. The donor was a woman who had been pronounced brain dead and was a match for Culp's age, race and skin complexion. The new face included the nose, upper lip, lower eyelids, upper jaw, incisor teeth, palate and various glands, as well as bones and ligaments. Culp, then 46, was given immunosuppressant drugs to prevent rejection.

Before operating, surgeons weren't sure if all of the donor tissue could be supplied with blood through the facial arteries, but bleeding from the tissue during the surgery told them the facial arterial system would be enough, according to the report.

"It demonstrates not only a masterpiece of surgical technique but the importance of modern medical teamwork to accomplish this patient's goals," Larrabee said. "Technically, the ability to use just the facial blood vessels and not the deeper ones opens new possibilities. Eventually this operation could become standard for severe facial injuries."

Dr. Laurie Casas, a clinical associate professor of surgery at the University of Chicago Pritzker School of Medicine, said much more needs to be learned before facial transplants become anything more than experimental. Some of the key questions that need to be answered are the long-term impact on patients, including to what extent they are able to return to normal activities, such as work and socializing.

"We are all so excited about the fact that it can be done. The question is, 'On whom should it be done? And when should it be done'?" Casas said. "The world, including the United States, is just beginning to understand how face transplants will really fit into our reconstructive efforts."

Culp will likely have another surgery later this year to remove extra glandular tissue around her lower jaw. If surgeons get their wish, the final outcome will look remarkably like a normal face.

"If the promising initial results continue, the operation may become standard of care for extensive facial injuries," according to the report.

In related news from the same journal, researchers from the University of Texas Medical School found that rib cartilage from human donors is an alternative to the patient's own rib cartilage in nasal plastic surgery.

Though the patient's own rib cartilage is the preferred choice, it's not always suitable, researchers write. A review of medical records of 357 patients who underwent nasal plastic surgery using irradiated donor cartilage found a complication rate of 3.25 percent, no greater than the complication rate when the patient's own cartilage was used. Irradiation decreases the chances of rejection, according to the study.

During an average follow-up of nearly eight years, about 94 percent of patients reported being satisfied with their appearance, ability to breathe and quality of life.

More information

The United Network for Organ Sharing has more on transplants.

SOURCES: Wayne Larrabee, Jr., M.D., clinical professor, head and neck surgery, University of Washington, Seattle; Laurie Casas, M.D., clinical associate professor of surgery, University of Chicago, Pritzker School of Medicine, Chicago; November/December 2009, Archives of Facial Plastic Surgery

Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Physician bias might keep life-saving transplants from black and Hispanic patients
2. Stem Cells May Offer Alternative to Lung Transplants
3. African Americans Fare Worse After Undergoing Liver Transplantation Due to Hepatitis C
4. Kidney transplants generally safe for lupus patients
5. Extending treatment after liver transplant may benefit patients with hepatitis C recurrence
6. Women Are at Greater Risk Than Men of Graft Loss After Undergoing Liver Transplantation for Hepatitis C-related Liver Disease
7. Important new novel 2009 H1N1 flu advisory for cardiopulmonary transplantation
8. Transplant May Treat Metabolic Disorders in Womb
9. Heart Test Deemed OK Before Kidney Transplant
10. STEMCELL Technologies Inc. Introduces MethoCult Express for Cord Blood Banks and Transplant Centers
11. National Health Care Reformers Should Pay Attention to Lawsuit Alleging that Nations Largest Insurer Routinely Denies Liver Transplants
Post Your Comments:
(Date:12/1/2015)... San Diego, CA (PRWEB) , ... December 01, ... ... simplicity and scale , Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of ... Ease® mobile imaging results enhancements at the Radiological Society of North America (RSNA) ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator ... the latest addition to the devices for sale in the United States. Clarity ... and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that is easy to ...
(Date:12/1/2015)... ... December 01, 2015 , ... PartnerTech ... through membership and leadership since 2008. Gary Bruce, President of PartnerTech North America, ... has spent a significant amount of time in Sweden since joining PartnerTech based ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... on receiving the 2015 HSJ Acute Sector Innovation Award on November 18th. This ... patient care experience, and propose exciting enhancements to the medical landscape. , The ...
(Date:11/30/2015)... , ... November 30, 2015 , ... Trevor and Taylor ... as they play for the chance to represent the United States. This hybrid ... to be a part of their journey in addition to offering corporate sponsors with ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Germany , December 1, 2015 ... manufacturer of eye and gaze tracking solutions, today announced ... eye trackers as a component of its revolutionary new ... sight, and medical and performance issues in patients. The ... SMI,s mass-market-ready eye tracking platform, which is ready to ...
(Date:12/1/2015)... -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced ... 2016 as the ex-distribution date for Ampio,s previously announced ... Stock of Aytu BioScience, Inc. As announced, Ampio will ... every five (5) shares of Ampio Common Stock owned ... date will be January 4, 2016. ...
(Date:12/1/2015)... , Dec. 1, 2015 Research and ... of the "2016 Global Enteric Disease Testing ... Salmonella, Shigella, Vibrio, Yersinia--France, Germany, Italy, Japan, Spain, ... Japan . --> ... The report is based on a combination ...
Breaking Medicine Technology: